11 studies found for: Open Studies | "Pneumococcal Infections"
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Early Versus Delayed Pneumococcal Vaccination in HIV
|3||Not yet recruiting||
Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
|6||Not yet recruiting||
Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso
|7||Not yet recruiting||
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
|8||Not yet recruiting||
Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) in the Young and Elderly
Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
|11||Not yet recruiting||
Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
† Indicates status has not been verified in more than two years